Constantiam Biosciences
Constantiam Biosciences is the resource for functional evidence in clinical genetics. By offering in-depth curation, rigorous analysis, and clear presentation of data from high-throughput genetic variant studies, MAVEvidence significantly boosts productivity and saves time for professionals in the field.
$20.05M
Latest Funding
Grant
Latest Funding Stage
2024-09-09
Funding Date
11
Employees
United States
Location
Houston, Texas
City & State
Sales-Ready Summary
Constantiam Bio recently received a $20M grant and is hiring for science, engineering, and technology roles, indicating potential expansion and new project development.
Key Contacts
Open Positions
View Careers PageHiring For
Similar Startups
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that focuses on developing innovative technologies for drug discovery. The company utilizes advanced live-cell resolution microscopy and engineering to identify and create new therapeutic candidates. Eikon Therapeutics aims to enhance the understanding of biological processes at a cellular level,supporting targeted treatment development.
Arsenale Bioyards
Arsenale is transforming biomanufacturing with a proprietary end-to-end platform that integrates advanced hardware, AI-driven software, and precision fermentation. Designed to bridge the gap from lab-scale innovation to industrial-scale production, Arsenale enables industries like food, chemicals, and materials to seamlessly develop and scalebio-based alternatives to petrochemicals and animal-derived products.
EvidenceHunt
EvidenceHunt is an AI-powered research assistant developed by medical professionals for healthcare research. Our focus is on delivering tools that streamline gathering and analyzing clinical evidence. With features like AI Chat for interactive queries and comprehensive Direct Search options, EvidenceHunt allows precise data retrieval andanalysis.
Avitia
Avitia improves cancer treatment via advanced molecular testing solutions. Avitia offer testing tools for use on-site, bioinformatics driven by AI, and actionable insights aimed at enhancing patient outcomes. Avitia offerings comprise pre-prepared NGS panels, simplified reporting mechanisms, and cooperative diagnostic platforms.